Patents
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
10/2014
10/14/2014US8858959 Gel vaccine delivery system for treating poultry
10/14/2014US8858927 Method for protection of peptides or proteins against non-enzymatic deamidation
10/14/2014US8858924 Compositions and methods for treatment of hemorrhage
10/14/2014US8858919 Method of providing fast relief to a user of a nicotine chewing gum
10/14/2014US8858918 Chewing gum and confectionery compositions with encapsulated stain removing agent compositions, and methods of making and using the same
10/14/2014US8858917 Methods for limiting spread of pulmonary infections
10/14/2014US8858912 Frozen compositions and methods for piercing a substrate
10/14/2014US8858210 Manufacture of variable density dosage forms utilizing radiofrequency energy
10/09/2014WO2014165842A2 Nanoparticle formulations in biomarker detection
10/09/2014WO2014165829A2 Nanoparticle formulations
10/09/2014WO2014165779A1 Drug combinations to treat cancer
10/09/2014WO2014165736A2 Esters of 2-deoxy-monosaccharides with anti proliferative activity
10/09/2014WO2014165728A1 Particles having peg-ylated surfaces modified for lymphatic trafficking
10/09/2014WO2014165672A1 Nanoparticle therapeutic agents, their formulations, and methods of their use
10/09/2014WO2014165617A1 Mesoporous alum nanoparticles as universal platform for antigen adsorption, presentation, and delivery
10/09/2014WO2014165607A2 Aromatic-cationic peptide formulations, compositions and methods of use
10/09/2014WO2014165582A1 Articles and methods related to transdermal delivery of a therapeutic agent
10/09/2014WO2014165566A1 Hydrophilic particle compositions, processes of production, and uses in dietary management and digestive disorders
10/09/2014WO2014165561A2 Delivery system for saw palmetto extract and carotenoid
10/09/2014WO2014165308A2 Microsphere drug delivery system for sustained intraocular release
10/09/2014WO2014165303A1 Tiotropium dry powders
10/09/2014WO2014165302A1 Treatment of disease with poly-n-acetylglucosamine nanofibers
10/09/2014WO2014165239A1 Chelation suppository for improved drug delivery
10/09/2014WO2014165008A1 Method of enhancing bioavailability of dha and other lipid-soluble nutrients
10/09/2014WO2014164957A1 Nanoparticulate and macroparticulate formulations
10/09/2014WO2014164904A1 Compositions and their use to treat complications of aneurysmal subarachnoid hemorrhage
10/09/2014WO2014164754A1 Injectable controlled release composition comprising high viscosity liquid carrier
10/09/2014WO2014164712A1 Formation and uses of europium
10/09/2014WO2014164509A1 Method and apparatus for differentiating oral pouch products
10/09/2014WO2014164280A1 Micronized pharmaceutical compositions
10/09/2014WO2014163558A1 Nanoparticles, composed of sterol and saponin from quillaja saponaria molina process for preparation and use thereof as carrier for amphipatic of hydrphobic molecules in fields of medicine including cancer treatment and food related compounds
10/09/2014WO2014163520A1 Preparation for treating proctological, urological and gynaecological diseases
10/09/2014WO2014163492A1 Composition as auxiliary means for oral medication
10/09/2014WO2014163400A1 Pharmaceutical composition for parenteral administration, containing donepezil
10/09/2014WO2014163222A1 Metal oxide nanoparticle-based magnetic resonance imaging contrast agent with a central cavity
10/09/2014WO2014163221A1 Metal oxide nanoparticle-based t1-t2 dual-mode magnetic resonance imaging contrast agent
10/09/2014WO2014163142A1 Ophthalmic composition
10/09/2014WO2014163132A1 Solid composition of amino carboxylate salt
10/09/2014WO2014163030A1 Preparation for treating equine inflammation
10/09/2014WO2014162930A1 Oil-in-water emulsion composition
10/09/2014WO2014162906A1 (sugar chain)-polypeptide complex
10/09/2014WO2014162515A1 Peritoneal dialysis fluid
10/09/2014WO2014162311A1 Adjustable sol-gel-based capsules comprising fragrances and aromas, and uses thereof
10/09/2014WO2014162288A1 Capsule with internal diaphragm
10/09/2014WO2014162252A1 Filler composition for the treatment of lipoatrophy
10/09/2014WO2014161837A1 Treatment of diabetes mellitus by long–acting formulations of insulins
10/09/2014WO2014161836A1 Treatment of metabolic disorders in equine animals
10/09/2014WO2014161085A1 Schiff-based aldehydic hyaluronic acid-chitosan hydrogel compositions and uses thereof
10/09/2014WO2014161036A1 Stimulus responsive substrates
10/09/2014WO2014161031A1 Nanoparticles for drug delivery comprising albumin having a polymer chain coupled thereto
10/09/2014WO2013102907A9 Ophthalmic composition
10/09/2014US20140303574 Adhesive patch assembly with overlay liner and system and method for making same
10/09/2014US20140303571 Titratable dosage transdermal delivery system
10/09/2014US20140303260 Pharmaceutical compositions of resveratrol
10/09/2014US20140303252 Osmotic drug delivery system
10/09/2014US20140303250 Pharmaceutical Solid Compositions Containing Ibuprofen Salts
10/09/2014US20140303227 Transmucosal hormone delivery system
10/09/2014US20140303215 Topically applicable pharmaceutical preparation
10/09/2014US20140303214 Transmucosal drug delivery system
10/09/2014US20140303192 Compounds and compositions for treating chemical warfare agent-induced injuries
10/09/2014US20140303189 Patch
10/09/2014US20140303145 Pharmaceutical composition comprising a poorly water-soluble active ingredient, a surfactant and a water-soluble polymer
10/09/2014US20140303131 Orally administered corticosteroid compositions
10/09/2014US20140303129 Methods of treating testosterone deficiency
10/09/2014US20140303128 Transmucosal hormone delivery system
10/09/2014US20140303107 Drug formulations
10/09/2014US20140302213 Method for manufacturing pure guar flour
10/09/2014US20140302157 Nanoparticle formulations and uses therof
10/09/2014US20140302156 Rigid shaped article for the treatment of itching
10/09/2014US20140302154 Magnetic transducers
10/09/2014US20140302152 Granulates comprising eslicarbazepine acetate
10/09/2014US20140302151 Methods and compositions for treating pain
10/09/2014US20140302150 Dpp-iv inhibitor formulations
10/09/2014US20140302149 Selective Chemokine Modulation
10/09/2014US20140302148 Cannabinoid formulations
10/09/2014US20140302147 Respirable agglomerates of porous carrier particles and micronized drug
10/09/2014US20140302146 Ophthalmic Aqueous Composition
10/09/2014US20140302145 Pharmaceutical composition for treating cancer using carbonate apatite nanoparticles
10/09/2014US20140302144 Multi-layered injectable self-assembling peptide scaffold hydrogels for long-term sustained release of human antibodies
10/09/2014US20140302143 Controlled Release and Taste Masking Oral Pharmaceutical Compositions
10/09/2014US20140302142 Compositions and methds for enhancing penetration of biologically active substances into tissues or organs
10/09/2014US20140302141 Triple Combination Release Multi-layered Tablet
10/09/2014US20140302140 Gaba analog prodrug sustained release oral dosage forms
10/09/2014US20140302139 Controlled Release and Taste Masking Oral Pharmaceutical Compositions
10/09/2014US20140302138 Extended release pharmaceutical compositions containing carbamazepine
10/09/2014US20140302136 Delivery system for saw palmetto extract and carotenoid
10/09/2014US20140302134 Formulation for the controlled release of one or several substances in the digestive tract of a mammal
10/09/2014US20140302133 Capsule with internal diaphragm
10/09/2014US20140302132 Pharmaceutical composition comprising nanocrystals
10/09/2014US20140302131 Oral formulations containing hyaluronic acid for sustained drug release
10/09/2014US20140302130 Silica-matrix forming compositions, materials formed therefrom, and methods of using the same
10/09/2014US20140302127 Novel formulation of metaxalone
10/09/2014US20140302126 Rhein or diacerein compositions
10/09/2014US20140302123 Products useful for the treatment of malignant neoplasms of the human nervous system
10/09/2014US20140302121 Cannabinoid Receptor Binding Agents, Compositions and Methods
10/09/2014US20140302119 Microvesicles carrying small interfering rnas preparation methods and uses thereof
10/09/2014US20140302118 Hydrous adhesive skin patch
10/09/2014US20140302117 Tissue products including a temperature change composition containing phase change components within a non-interfering molecular scaffold
10/09/2014US20140302116 Compositions and methods for nucleic acid delivery
10/09/2014US20140302115 Drug delivery system based on polyethylene vinylacetate copolymers
1 ... 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 ... 2991